Q4 2024 Dexco SA Earnings Call Transcript
Key Points
- The Wood division consistently boosted its results throughout 2024, driven by strong demand from the furniture industry and retail sector.
- The Metals and Sanitary Ware division showed recovery compared to 2023, with operational execution improving due to a market upturn.
- LD Celulose delivered record revenue and EBITDA in 2024, benefiting from operational efficiency and effective cost management.
- Dexco SA (BSP:DXCO3) achieved an adjusted and recurring EBITDA of BRL2.4 billion in 2024, a 22% increase compared to 2023.
- The company successfully managed its liabilities, reducing the average cost of debt while maintaining the average term.
- The ceramic tiles sector remains under pressure, with a recovery still challenging due to a previous 30% drop in 2022 and 2023.
- Net income showed a negative result for the quarter and the year due to restructuring of LD Celulose's financing.
- The Tiles division faced increased costs and competitive pressures, resulting in a low adjusted and recurring EBITDA margin of 0.5% for 2024.
- The macroeconomic scenario remains challenging, with higher interest rates and volatile foreign exchange rates impacting costs.
- Dexco's leverage levels were around 3.01 times net debt-to-EBITDA, indicating a need for continued focus on deleveraging.
Good morning, ladies and gentlemen, and welcome to Dexco's earnings call for the fourth quarter of 2024. This conference call is being recorded. You may access this recording at the company's website, ri.dex.co. This presentation is also available for download. This call is also available in English. (Operator Instructions).
Before we continue, we would just like to state that any prospective statements are based on the company's beliefs and assumptions. This is based on currently available information for the company. These statements may involve risks and uncertainties as they refer to future events that, therefore, depend on circumstances that may not occur.
Investors, analysts, and journalists should take into account that any events related to the macroeconomic scenario to the industry and other factors may make these results differ materially from those expressed in these forward-looking statements. We have with us the Executive Board and the Investor Relations team from Dexco.
I would now like to give the floor to Francisco Semeraro, the company's CFO, who will begin the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
